The use of the ammonia deprotection step to introduce 15 N labels at specific exocyclic amino positions of adenine, cytosine, guanine or 2-aminopurine of oligodeoxynucleotides is described.
INTRODUCTION
One of the problems found during the structural elucidation of synthetic oligonucleotides by NMR is the difficulty in detecting the amino protons. The introduction of a 15 N label in the exocyclic amino group in combination with special pulse techniques allows the selective observation of specific base pairs. The methodology described for introduction of I5 N into oligonucleotides is based on the preparation of 15 N labelled nucleoside derivatives conveniently protected for DNA synthesis 1 " 8 . Recently, the development of nucleoside derivatives that can be transformed to different nucleoside analogues during deprotection has been described 9 " 12 . This method, named 'the convertible nucleoside approach', has been used very recently to prepare an oligodeoxynucleotide containing a cytidine 15 N labelled at position 4 13 . In the present communication we describe the preparation of oligodeoxynucleotides containing a 15 N label at the exocyclic position of any of the three natural bases that have amino groups (A, C, and G) and a non-natural, mutagenic base (2-aminopurine). The methodology described here uses the ammonia deprotection step to incorporate the 15 N label. Previous reports have shown that this strategy is succesful for the specific labeling of exocyclic amino groups of cytidine residues in DNA 13 " 15 .
RESULTS AND DISCUSSION

Selection of nucleoside precursors
The aim of this work is to use 15 N aqueous ammonia solution to deprotect and introduce a I5 N label at a predetermined exocyclic amino group in oligodeoxynucleotides. First of all it was necessary to check whether commercially available 15 N aqueous ammonia, supplied as a 3.3 N solution, is sufficient to deprotect standard solid phase protecting groups (Bzl for A and C and ibu for G). The concentration of aqueous ammonia normally used for oligonucleotide deprotection is 15 N but the large excess of ammonia can be reduced if longer deprotection times are used, especially if oligonucleotides are short (as it is the case in oligonucleotides for NMR studies). The hexamer 5'GCTAGC 3' was prepared using standard solid phase oligonucleotide synthesis protocols. Deprotection was run with 3.3 N aqueous ammonia (0.3 ml for 10 mg of oligonucleotide-CPG) at 60°C for 2 days. HPLC analysis of the product gave a major product that had the correct nucleoside composition (data not shown). So, we conclude that 3.3 N aqueous solutions can be used for deprotection of short oligonucleotides. It is obvious that a more concentrated ammonia solution (prepared by dissolving 15 NH 3 gas in water) could be used if desired.
The next step was to design and prepare suitable phosphoramidite derivatives. The following criteria were taken in account: a) the nucleoside derivative should be functionalized for DNA synthesis b) it should be stable to DNA synthesis conditions, and c) it should be transformed to the desired nucleoside with 3.3 N ammonia solutions in a reasonable time (not more than three days at 60°C) and without side-products (at least 95% purity).
Following these criteria we selected the 4-(l,2,4-triazolyl)-(dU figure 1 ). The phosphoramidites of dlF" and C^-aryl-dU have been used to prepare oligonucleotides containing 15 N labeled cytidine 13 15 N amino groups at the position 2 of guanine and 2-aminopurine, we have selected the corresponding 2-fluoropurine derivatives (figure 1). 2-Fluoro-dI derivatives have been described to react with amines giving several guanine derivatives at nucleoside 18 (Npe) group is needed for the preparation of 2-fluoro-dI derivative 18 "" 21 and, in principle it could be removed after the fluorination reaction 21 but it is preferable to leave it on during the preparation of the phosphoramidite and during DNA synthesis. 2-Fluoropurine-2'-deoxyriboside has not been previously described.
Finally, for the labelling of the exocyclic amino groups of adenine with 15 N we selected 6-fluoropurine, 6-chloropurine and O 6 -aryl-dI derivatives. Similarly to guanine, 6-fluoro and 6-chloro derivatives have been described to react with amines to produce adenine adducts at nucleoside 19 ' 22~24 and oligonucleotide 21 ' 25 level. On the other hand, O 6 -aryl-dI derivatives have been described for the preparation of oligonucleotides containing modified adenines 11 " 12 . Preparation of nucleoside precursors DMT-dU 1 " phosphoramidite was prepared by reacting DMT-dU phosphoramidite with phosphoryl tris(l,2,4-triazolide) as described by Webb and Matteucci 26 . The fluorescent derivative was purified by silica gel as described for the T 1 " derivative 27 obtaining the desired product in a 35% yield. The yield is lower than the yield obtained for the V" derivative due to partial decomposition during the silica gel purification. As observed by MacMillan and Verdine 9 the absence of the methyl group at position 5 in the uracil derivative makes the triazolyl derivative more reactive and consequently more difficult to isolate.
DMT-dU et was obtained by reacting DMT-dU with phosphoryl tris(l,2,4-triazolide) followed by displacement of the triazolyl group with sodium ethoxide 16 in a 60% overall yield. Phosphorylation of the 3'-OH was prevented by protection with the trimethylsilyl group with trimethylsilyl-l,2,4-triazole as described for DMT-O 4 -ethyl-T 16 . The phosphoramidite derivative was prepared following standard protocols.
2-Fluoropurine 2'-deoxyriboside was prepared by enzymatic glycosylation (figure 2). First, 2-fluoropurine (2) was prepared in a 64% yield by reacting 2-aminopurine (1) with sodium nitrite and tetrafluoroboric acid 28 . Conversion of 2-fluoropurine (2) to its 2'-deoxyriboside (3) was performed using 2'-deoxycytidine as glycosil donor and extracts from Lactobacillus helveticus containing rra/w-N-glycosylase 29 . After silica gel purification, compound 3 was obtained in a moderate (46%) yield contaminated with 2-fluoropurine. This mixture was used for the preparation of the DMT derivative (4) that was reacted with chloro-N,N-diisopropyl-0-2-cyanoethyl phosphine to obtain the phosphoramidite 5.
2-Fluoropurine-O 6 -Npe-2'-deoxyinosine (8) was prepared by fluoride displacement of the diazonium derivative of O 6 -Npe-dG (7)i8-2i -p w 0 different protocols have been tried. First, compound 7 was reacted with sodium nitrite and tetrafluoroboric acid in water-acetone mixtures. Second, the same compound was reacted with f-butylnitrite and HF/pyridine in anhydrous media 30 . In both methods yields were moderate and some depurination was observed. The yield from the aqueous protocol was slightly better. Compound 7 was prepared following the method described by the group of Pfleiderer 31 . The corresponding phosphoramidite (10) was prepared following standard protocols.
6-Chloropurine 2'-deoxyriboside (14) was the key product for the preparation of different adenine precursors (figure 4). This product is usually prepared 21 " 25 from 2'-deoxyinosine following the method described by Robins and Basom 32 . We attempted the direct replacement of the 6-amino group of dA by chlorine described by Nair and Richardson 33 because the starting dA is less expensive than dl. 3',5'-O-bis (fert-butyldimethylsilyl)-dA (12) was reacted with 1-pentyl nitrite 34 in CC1 4 giving only the desired 6-chloro intermediate (13) that was isolated in good yields (63%). The formation of the dl derivative described by Gao and Jones 2 was not observed. The different results observed could be due to the presence of water during diazotization reaction coming from tetraethylammonium chloride used by these authors as catalyst. 6-Fluoropurine 2'-deoxyriboside (15) was prepared after two consecutive nucleophilic displacements at position 6. First chlorine was displaced by N-methylpyrrolidine and the resulting tetraalkylammonium salt was reacted with KF without isolation. The method described is a modification of the standard trimethylamine-mediated synthesis of 6-fluoropurines 32 ' 35 and the use of N-methylpyrrolidine is preferred because it is easier to handle than trimethylamine. Compound 15 was the only product formed as judged by TLC and HPLC but attempts of isolation by silica gel column chromatography failed probably due to depurination during purification. When the crude preparation was reacted with DMT chloride in pyridine, the DMT derivative was formed and it could be isolated but with low yields (16% from compound 14). The corresponding phosphoramidite was prepared following standard protocols. The same route was used for the preparation of O 6 -phenyl (16) and O
6
-pentafluorophenyl (17) 2'-deoxyinosine derivatives (figure 4). These compounds were isolated by silica gel column chromatography with good yields.
Reactivity of nucleoside precursors to diluted ammonia
Prior to oligonucleotide synthesis, nucleoside precursors were treated with 3.3 N ammonia solution at 60°C in order to estimate the time needed to complete the ammonia displacement reaction. 2'-Deoxyuridine derivatives (dU tri and dU el ) were not tested because displacement was known to occur by diluted aqueous ammonia in less than 10 hours by previous work with related T and U derivatives 14 " 16 . Analysis of the products formed was done by analytical reverse phase HPLC. Table 1 shows the results obtained. All the nucleoside precursors gave the desired 2'-deoxynucleoside in 1 day of reaction except for 2-fluoro-O 6 -Npe-dI (7) and O 6 -phenyl-dI (16) . In compound 7, the displacement of the fluoride atom was faster but the removal of the Npe group was very slow. Similarly, 2-fluoro-dI without the Npe group was transformed to dG more rapidly and together with 2-fluoropurine 2'-deoxyriboside the ammonolysis was complete after 24 hours. 6-Modified nucleoside precursors were more reactive than 2-modified compounds. 6-Fluoropurine 2'-deoxyriboside (15) was converted to dA in less than 2 hours. 6-Chloropurine 2'-deoxyriboside (14) and 0 6 -pentafluorophenyldl (17) had similar reactivity (an overnight treatment is needed for completion). O 6 -phenyl-dI (16) was the last reactive adenine precursor that we made and hence was not used further.
Oligonucleotide syntheses
Sequences shown in table 2 were prepared on an automatic DNA synthesizer using standard 2-cyanoethyl phosphoramidites and the modified 2-cyanoethyl phosphoramidites described above.
Heptamers 5'GCGU tri GCC 3' and 5'GCGU et GCC 3' were used to compare the two cytidine precursors. Oligonucleotide supports were treated with 99% 15 N aqueous ammonia at 60 °C for 3 days. One ml of commercially available 3.3 N solution was used for a 2 -3 mmol synthesis. After HPLC purification, the 15 N labelled heptamer was obtained in a 68% yield when O 4 -ethyl-dU was used and in a 48% yield with the triazolyl derivative. Enzymatic digestion of the oligonucleotide showed the presence of a small amount of dU as side product coming from the hydrolysis reaction instead of the ammonolysis. The sequence prepared with the triazolyl derivative showed a small amount of dU that corresponds to a 92% purity at the The complementary 9mer was prepared using the 2-aminopurine precursor, 2-fluoropurine phosphoramidite (5). 15 NAmmonia deprotection yielded a major product that was shown to contain the desired 2-aminopurine by HPLC analysis of the enzymatic digestion. The retention time and the characteristic UV spectrum of the nucleoside confirmed the presence of the mutagenic analogue. Neither starting 2-fluoropurine 2'-deoxyriboside or side-products were observed. Proton and 15 N NMR spectra confirmed the structure and N selective labelling of the oligonucleotide (data not shown).
A 20 mer oligonucleotide was prepared using compound 10 as the guanine precursor. After the assembly of the sequence, one half of the support was treated directly with N aqueous ammonia and the other half was treated with DBU to remove the Npe group prior the ammonia treatment. The sample that was treated with ammonia directly showed after 3 days of treatment at 60°C two peaks with a similar retention time. The HPLC analysis of the enzymatic digestions showed that the first 
peak was the desired oligonucleotide and second eluting peak was the 20 mer that contained O 6 -Npe-dG. On the contrary, the support treated previously with DBU gave only the desired oligonucleotide containing 2-15 N-dG. So, it could be concluded that elimination of the Npe group with DBU prior ammonia treatement is needed to obtain a complete conversion and deprotection of the guanine precursor.
A dodecamer was prepared using the phosphoramidites of compounds 14, 15 and 17 as adenine precursors. Deprotection and modification were carried out with 15 N-ammonia aqueous solution as described above. Surprisingly, the HPLC chromatograms obtained with the product coming from the 6-halo derivatives 14 and 15 contained very small amounts of the desired dodecamer. Instead a shorter oligonucleotide was obtained as the major component. This side-product had a nucleoside composition that corresponds to a sequence truncated at the modified nucleoside. On the other hand, the oligonucleotide prepared with compound 17 presented a correct HPLC chromatogram with a major component that had a correct nucleoside composition. Because coupling efficiencies of the phosphoramidites were high, we thought that a severe depurination during the synthesis followed by b-elimination of die apurinic site during the long ammonia treatment was the reason of the failure of the 6-halo derivatives. In order to check that hypothesis, we have measured the depurination rates of compound 14 and 17. The half lives of compounds 14 and 17 in 2% trichloroacetic acid in dichloromethane were 20 min and 100 min respectively. Also, the same sequence was prepared using 6-chloropurine phosphoramidite and, after the addition of the 6-chloropurine nucleoside, detritylation was carried out manually with 2M zinc bromide in dichloromethane/isopropanol (85:15). Using these conditions, depurination was reduced and the amount of desired dodecamer was much higher. But, the best yield was obtained when the phosphoramidite of compound 17 was used. HPLC analysis of the enzymatic digestion of the desired dodecamer, show the correct nucleoside composition. Neither starting compound (17) or side-products were observed. 15 N and proton NMR spectra confirmed the presence of [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] N adenine at the desired site ( figure 6 ).
In conclusion, we have shown that the amino groups of the three natural bases and 2-aminopurine could be labeled with 15 N using the ammonia deprotection step. For that purpose, different nucleoside precursors have been prepared, introduced to synthetic oligonucleotides and tested for their ability to be labeled with 15 N aqueous ammonia. In agreement to previous reports 14 " 15 , the phosphoramidite of U 1-Pentyl nitrite was prepared as previosuly described 34 . 7rans-N-deoxyribosylase was isolated from Lactobacillus helveticus as described previously 29 . DMT-dU 1 " N,N-diisopropyl-2-cyanoethyl phosphoramidite was prepared esentially as described in ref. 26 and 27 ("P-NMR (CDC1 3 , 121 MHz) : 146.3 and 146.8 ppm). DMT-dU et N,N-diisopropyl-2-cyanoethyl phosphoramidite was prepared following the method described for the O-4-ethylthymidine derivative 16 . O 6 -Npe-dG (7) was prepared following the method described by Schirmeister et al. with minor modifications 31 . 99% 15 N-Ammonia aqueous solution (3.3 N) was purchased to SDS (Isotopchim, France).
2-Fluoropurine (2)
2-Aminopurine (1) (1.35 gr, 10 mmol) was dissolved in 30 ml of 48% aqueous HBF 4 (3 ml/mmol of purine). The solution was cooled at -10°C and 1.2 g (17 mmol) of sodium nitrite dissolved in water (5 ml) were added dropwise during 40 min. After the addition the mixture was stirred for 15 min and the temperature was raised to 0 °C. The reaction was neutralized to pH 6 with 50% aqueous NaOH and the slurry was evaporated to dry ness. The residue was loaded onto a silica gel column with a 10% MeOH solution in DCM and a 10 to 50% MeOH gradient in DCM was used to elute the product giving 0.89 g (64% yield) of a white solid. R f (DCM/MeOH 8:2) : 0.84. 'H-NMR (DMSO-de, 300 MHz) : 9.0 (s, 1H, H-6); 8.6 (d, 1H, H-8, 2.1 Hz). 19 F-NMR (DMSO-ds, TFA as standard, 282 MHz) : 23.1 (s, IF, F-2).
2-Fluoropurine 2'-deoxyriboside (3)
400 mg of 2-fluoropurine (2) (3.0 mmol) was dissolved in 300 ml of water with 3.5 gr of 2'-deoxycytidine (15.7 mmol) as 2'-deoxyribose donor, 12 ml of the enzyme preparation (ref. 28 , 0.07 units/ml) and 150 ml of 0.15 M Tris maleate buffer pH 6. The reaction was mantained at 37°C for 7 hours. The reaction mixture was heated with boiling water for 6 -7 min to denature 
5'-O-(4,4'-dimethoxytrityl) 2-fluoropurine 2'-deoxyriboside (4)
300 mg of the product obtained from enzymatic glycosylation (approx. 1 mmol) were dried by coevaporation of dry pyridine. The residue was dissolved in 10 ml of pyridine and 338 mg of dimethoxytrityl chloride (1 mmol) were added. After magnetic stirring for 16 hours MeOH (0.5 ml) was added and the mixture was concentrated to dryness. The residue was purified by column chromatography (silica gel) eluted with a 0 to 2 % MeOH gradient in DCM giving 140 mg (25% yield) of a yellowish oil. in pyridine at -30°C, 2 ml of 65% HF / pyridine and 0.083 ml (0.7 mmol) of f-butylnitrite were added. After 5 min of magnetic stirring at -30°C, the solution was neutralized with 50% aqueous sodium hydroxide and concentrated to dryness. The residue was purified on a silica gel column eluted with a 3 -20% MeOH gradient in DCM. Yield 40 mg (20%). The product presented the same HPLC and NMR characteristics than the product obtained by method 1.
2'-Deoxy-2-fluoroinosine
2'-Deoxy-2-fluoro-0 6 "Npe-guanosine (8) (10 mg, 2.3 mmol) was treated with 1.5 ml of 0.5 M DBU in dioxane. After 5 hours of magnetic stirring, the solution was neutralized with 50% aqueous acetic acid and concentrated to dryness. The product was purified by column chromatography (silica gel) using a 5 to 20% MeOH gradient in DCM. Yield : 3 mg (48%). 19 F-NMR (282 MHz, CDC1 3 , TFA as reference) : 25.4 ppm (s).
5'-O-(dimethoxytrityl)-2'-deoxy-2-fluoro-O 6 [2-(4-nitrophenyl)ethyl] inosine (9)
To a solution of 2'-Deoxy-2-fluoro-0 6 -Npe-guanosine (8, 300 mg, 0.7 mmol, coevaporated twice with dry pyridine) in 10 ml of dry pyridine, dimethoxytrityl chloride (291 mg, 0.86 mmol) was added and kept at room temperature for 5 hr. MeOH was added (1 ml) and the mixture was evaporated. The residue was dissolved in DCM and 5% aqueous sodium bicarbonate. The organic phase was separated, washed with saturated aqueous sodium chloride, dried with anhydrous sodium sulphate and evaporated to dryness. The residue was purified by column cromatography (silica gel) eluted with a 0 -5 % MeOH gradient in DCM. Yield : 300 mg (58%). 3',5'-Di-tert-butyldimethylsilyl-2'-deoxyadenosine (12) 2'-deoxyadenosine (11) (1 g, 5.8 mmol) and imidazole (3.2 g, 48 mmol) were dried by coevaporation with anhydrous toluene. To the residue 20 ml of anhydrous DMF and 3.6 g of tertbutyldimethylsilyl chloride (24 mmol) were added and the mixture was stirred overnight at room temperature. Solvent was removed using a vacuum pump and the residue was dissolved in DCM. The organic solution was washed with water, dried with anh. sodium sulphate and evaporated to dryness. The residue was purified by silica gel column chromatography eluted with a 0 -5 % MeOH gradient in DCM giving 2. 3',5'-Di-*er*-butyldimethylsilyl-6-chloropurine 2'-deoxyriboside (13) 3',5'-Di-ferf-butyldimethylsilyl 2'-deoxyadenine (12) (2.8 g, 5.8 mmol) was dried by coevaporation with dry toluene. The residue was dissolved with 100 ml of CC1 4 and 1.75 ml (13.1 mmol) of 1-pentyl nitrite 34 were added. The mixture was heated at 80°C under argon atmosphere and irradiated with a 200 watt lamp. After one hour the mixture was evaporated and the residue was purified by silica gel chromatography eluted with a 1 -2% gradient of MeOH in DCM giving the desired product as an oil (1.8 g, 63% yield). R f (CH 2 C1 2 / MeOH 95:5) : 0.86. 'H-NMR (CDCI3) : 8.63 and 8.32 (s, 2H, H-2 and H-8); 6.42 (t, 1H, H-l'); 4.50 (m, 1H, H-3'); 3.88 (m, 1H, H^' ) ; 3.78 (m, 1H, H-5'); 3.69 (m, 1H, H-5'); 2.81 (m, 1H, H-2'); 2.36 (m, 1H, H-2'); 0.93 and 0.87 (s, 18 H, fBuSi); 0.14 and 0.06 (s, 12H, CH 3 Si).
6-ChIoropurine 2'-deoxyriboside (14)
To a solution of 3',5'-di-rm-butyldimethylsilyl-6-chloropurine 2'-deoxyriboside (1.82 g, 3.6 mmol) in dry THF, a 1M solution of tetrabutylammonium fluoride (7.2 mmol) in THF was added. After 15 min, the reaction was completed and the solvent was removed by evaporation. The residue was dissolved in water, the solution was washed with ethyl ether and the aqueous layer was evaporated. The resulting oil was purified by silica gel chromatography eluted with a 5 -10% MeOH gradient in DCM to give the desired product as an oil (0.98 g, 100% yield). 
6-Fluoropurine 2'-deoxyriboside (15)
To a solution of 6-chloropurine 2'-deoxyriboside (14) (0.45 g, 1.7 mmol) in anhydrous DCM cooled with ice, 1.6 ml (14.9 mmol) of 1-methylpyrrolidine was added and the reaction mixture was stirred for 2 hours at 0°C. At that time, the reaction was complete as shown by the formation of the pyrrolidinium salt by TLC (R f = 0, DCM / MeOH 9:1). The reaction mixture was warmed at room temperature and evaporated to dryness. The resulting oil was used without further purification.
To a stirred suspension of potassium fluoride (spray dried, Fluka, 0.96 g, 1.7 mmol) in dry DMF mantained at 40°C, a solution of the pyrrolidinium salt (prepared as described above, 1.7 mmol) in DMF was added. After magnetic stirring for 4 hours at 40°C, the reaction mixture was cooled and filtered and the solution was concentrated to dryness. The resulting oil was used without further purification. Attempts at silica gel column purification at this stage resulted on low recoveries of the product. 
6-O-phenyl-2'-deoxyinosine (16)
A solution of 0.3 g (1.1 mmol) of 6-chloropurine 2'-deoxyriboside (14) in dry DCM (20 ml) was cooled with ice and 1.1 ml (10 mmol) of 1-methylpyrrolidine were added. After magnetic stirring for 2 hrs at 0°C, phenol (11 mmol) and Et 3 N (0.5 ml, 3.3 mmol) were added and the mixture was heated under reflux for 2 hr and evaporated to dryness. The residue was purified on silica gel column chromatography eluted with a 5% MeOH solution in DCM to give compound 16 as an oil. Yield : 0.24 g (66%).
: H and 13 C-NMR identical to the product described by Ferentz and Verdine 12 .
6-O-pentafluorophenyl-2'-deoxyinosine (17)
A solution of 0.5 g (1.8 mmol) of 6-chloropurine 2'-deoxyriboside (14) in dry DCM (30 ml) was cooled with ice and 1.8 ml (16.6 mmol) of 1-methylpyrrolidine were added. After magnetic stirring for 2 hr at 0°C, pentafluorophenol (3.4 g, 18.5 mmol) and Et 3 N (0.77 ml, 5.5 mmol) were added and the mixture was refluxed for 2 hr and evaporated to dryness. 
Conversion of modified 2'-deoxynucleosides to their amino derivatives
Approx. 1 mg of each nucleoside derivative (see table 1) was treated with 0.5 ml of 3.3 N aqueous ammonia solution at 60°C. At different time intervals, an aliquot of the solution was taken and analyzed by HPLC (conditions A). In all cases, the conversion to the desired nucleoside gave only the desired product. The reaction of ammonia with 2'-deoxy-2-fluoroO^Npe-inosine (8) gave an intermediate product that coeluted with O^Npe-dG and this product slowly was converted to the desired dG.
Depurination studies
Approx. 1 mg of compounds 14 and 17 were disolved in 2% trichloroacetic acid in DCM (0.5 ml). At different times 0.1 ml aliquots were taken, neutralized with 0.1 ml of a 2 % triethylamine in DCM and the solvents evaporated. The residue was resuspended with MeOH / water (1:1) and analyzed by HPLC. 
Oligonucleotide synthesis
The sequences shown in table 2 were prepared on a Applied Biosystems automatic DNA synthesizer using standard 2-cyanoethyl phosphoramidites and the modified phosphoramidites described above.
Oligonucleotide-supports were treated with 99% 15 N aqueous ammonia (3.3 N solution) at 60°C for 2 -3 days. 1 ml of ammonia solution was used for 2-3 mmol synthesis. The oligonucleotide sample containing 2-fluoro-O 6 -Npe-dI was divided in two parts. One half was treated directly with N ammonia. The other half was treated first with a 0.5 M DBU solution in acetonitrile for one hour at room temperature (2 washes of 30 min), washed with acetonitrile, 1% solution of triethylamine in acetonitrile (to remove DBU) and acetonitrile, and after, the support was treated with 15 N ammonia. As described in results, the DBU deprotection before the ammonia treatment is important to obtain a complete removal of the Npe group. The ammonia solutions were concentrated to dry ness and the products were purified by reverse phase HPLC. All syntheses presented a major peak that was collected and analyzed by snake venom phosphodiesterase and alkaline phosphatase digestion followed by HPLC analysis of the nucleosides (conditions B) 16 . NMR measurements HPLC purified oligonucleotides were further purified by flow dialysis using a 1000 MWCO membrane against 200 -300 mM NaCl, 20-30 mM NaCl, and finally against 2 H 2 O for 1 day each. The final sample buffer contained 10 mM potassium phosphate in a 90:10 (vol/vol) H 2 O/ 2 H 2 O solution. The pH was 7.0 and the sample volume was 0.5 ml. DNA concentrations for samples were 0.4-2.0 mM in duplex.
Yield
NMR spectra were acquired on a Bruker AMX-600 spectrometer. All spectra were recorded at 25 °C. All 'H spectra were collected into 8192 data points using a spectral widht of 12000-13000 Hz. 256 scans were acquired, with a recycle time of 2s. The solvent resonance was suppressed using a 1 -1 pulse sequence. 15 N-filtered 'H spectra were obtained using a pulse sequence described previously 36 .
15
N spectra were collected into 8192 data points using a spectral width of 12000-19000 Hz. 14000-23000 scans were acquired, with a recycle time time of 2s.
Spectra were processed on a Silicon Graphics workstation using FELIX 2.30 (Hare Research). Prior to Fourier transformation, a convolution was applied to the free induction decays to remove the residual solvent resonance. The data were typically apodized with a skewed sine bell with a 60°C phase shift. The H 2 O resonance was used as a 'H chemical shift reference at 4.78 ppm. 15 N spectra were indirectly referenced to 15 NH 3 .
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